Jan A S Van Der Heyden
Overview
Explore the profile of Jan A S Van Der Heyden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
564
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Ginkel D, Bor W, Aarts H, Dubois C, De Backer O, Rooijakkers M, et al.
N Engl J Med
. 2024 Aug;
392(5):438-449.
PMID: 39216096
Background: One third of patients undergoing transcatheter aortic-valve implantation (TAVI) have an indication for oral anticoagulation owing to concomitant diseases. Interruption of oral anticoagulation during TAVI may decrease the risk...
2.
van Ginkel D, Bor W, Dubois C, Aarts H, Rooijakkers M, van Bergeijk K, et al.
EuroIntervention
. 2023 Aug;
19(9):766-771.
PMID: 37605804
About one-third of patients undergoing transcatheter aortic valve implantation (TAVI) use oral anticoagulants (OAC), mainly due to atrial fibrillation. General guidelines advise interrupting OAC in patients with a high risk...
3.
Pagnesi M, Kim W, Baggio S, Scotti A, Barbanti M, De Marco F, et al.
JACC Cardiovasc Interv
. 2023 Jul;
16(16):2004-2017.
PMID: 37480891
Objectives: The authors sought to evaluate the incidence, predictors, and outcomes of new permanent pacemaker implantation (PPI) after transcatheter aortic valve replacement (TAVR) with contemporary self-expanding valves (SEV). Background: Need...
4.
Scotti A, Baggio S, Pagnesi M, Barbanti M, Adamo M, Eitan A, et al.
Circ Cardiovasc Interv
. 2023 Jan;
16(1):e012538.
PMID: 36649387
Background: In recent years, transcatheter aortic valve replacement (TAVR) techniques and technology have continuously improved. Data regarding the impact of these advancements on outcomes in large real-world settings are still...
5.
Brouwer J, Nijenhuis V, Delewi R, Hermanides R, Holvoet W, Dubois C, et al.
N Engl J Med
. 2020 Sep;
383(15):1447-1457.
PMID: 32865376
Background: The effect of single as compared with dual antiplatelet treatment on bleeding and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients who do not have an indication for...
6.
Nijenhuis V, Brouwer J, Delewi R, Hermanides R, Holvoet W, Dubois C, et al.
N Engl J Med
. 2020 Mar;
382(18):1696-1707.
PMID: 32223116
Background: The roles of anticoagulation alone or with an antiplatelet agent after transcatheter aortic-valve implantation (TAVI) have not been well studied. Methods: We performed a randomized trial of clopidogrel in...
7.
Pagnesi M, Kim W, Conradi L, Barbanti M, Stefanini G, Schofer J, et al.
Am J Cardiol
. 2020 Feb;
125(9):1369-1377.
PMID: 32098656
Safety and feasibility of transfemoral Acurate neo implantation without systematic predilatation are not fully investigated. Our aim was to evaluate the use and impact of pre-implantation balloon aortic valvuloplasty (pre-BAV)...
8.
Gheorghe L, Rensing B, Van Der Heyden J, Eefting F, Post M, Rana B, et al.
Curr Cardiol Rep
. 2019 Mar;
21(5):37.
PMID: 30924027
Purpose Of Review: This review aims to provide an updated overview and a clinical perspective on novel transcatheter tricuspid valve interventions (TTVI), highlighting potential challenges and future directions. Recent Findings:...
9.
Pagnesi M, Kim W, Conradi L, Barbanti M, Stefanini G, Zeus T, et al.
JACC Cardiovasc Interv
. 2019 Mar;
12(5):433-443.
PMID: 30846081
Objectives: The aim of this study was to compare transcatheter aortic valve replacement (TAVR) with the Acurate neo (NEO) and Evolut PRO (PRO) devices. Background: The NEO and PRO bioprostheses...
10.
Zivelonghi C, Suttorp M, Teeuwen K, Van Kuijk J, Van Der Heyden J, Eefting F, et al.
JACC Cardiovasc Interv
. 2018 Nov;
11(22):2343-2345.
PMID: 30466836
No abstract available.